Actively Recruiting
Rare Tumors and Cancer Predisposition in Individuals and Families
Led by National Cancer Institute (NCI) · Updated on 2026-04-14
500
Participants Needed
2
Research Sites
668 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Some people may be prone to develop cancer for many reasons. Factors that affect their risk include the genes they inherit and the environment they live and work in. Researchers want to learn more about the natural history of cancer. Objective: To understand how genes and environmental factors can cause tumors and related conditions. Eligibility: People of any age who: Have tumors of an unusual type, pattern, or number Have a family member with a history of cancer Have been exposed to other factors that may increase their risk of cancer Design: This study does not involve treatment. Participants will answer questions about their personal and family medical history. They will give permission for researchers to see their medical records. Participants may be invited to the NIH Clinical Center for a physical exam. They may give samples including saliva, cheek cells, blood, urine, skin, and/or hair. Participants with cancer may give bone marrow. A needle will be used to remove a small sample of bone marrow from their hip bone. Participants may have a biopsy of their tumor. Participants may have other exams: Dental Ear, nose, and throat Eye Hearing Heart function and structure Participants with cancer may undergo more exams: A test of how much energy their body uses when resting A sleep study with a test that measures brain electrical activity. They will have sensors attached to their body while they sleep overnight in a lab. Imaging scans, such as CT, MRI, a test to measure how dense their bones are (DEXA), and ultrasound. Participants will have their genes tested. A counsellor will help them understand the results. Participants will be followed until at least 2035.
CONDITIONS
Official Title
Rare Tumors and Cancer Predisposition in Individuals and Families
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any person of any age, including neonates, may participate
- Personal history of unusual tumors by type, pattern, or number
- Known or suspected genetic, congenital, or environmental factors increasing cancer risk
- Family history of unusual tumors by type, pattern, or number
- Participant or their legally authorized representative must sign an IRB-approved informed consent form
- Children under 3 years old will only come to the Clinical Center if clinically indicated until age 3 or older
You will not qualify if you...
- Individuals or families with unverified reported cancer diagnoses
- Inability of participant or legally authorized representative to understand and sign informed consent
- Individuals or families eligible for other protocols specific to hereditary cancer syndromes such as Li-Fraumeni Syndrome or Familial Melanoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
2
NIH National Cancer Institute - Shady Grove
Rockville, Maryland, United States, 20850
Actively Recruiting
Research Team
N
NCI Family Study Referrals
CONTACT
S
Sharon A Savage, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here